Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severin Rodler

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Journal of Geriatric Oncology|June 23, 2020
Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancersGerald Bastian Schulz, Severin Rodler, Bernadett Szabados, et al.
Sexual Medicine|May 22, 2020
Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional StudySeverin Rodler, Johannes von Büren, Alexander Buchner, et al.
Infection|February 24, 2022
Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient populationAlexander Tamalunas, Melanie Schott, Troya Ivanova, et al.
MMW Fortschritte Der Medizin|July 7, 2023
[Systemic treatment of renal cancer and management of immunotherapy related toxicity]Elena K Berg, Can Aydogdu, Melanie Götz, et al.
Urologic Oncology|September 18, 2021
Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatmentAnnabel Spek, Anno Graser, Jozefina Casuscelli, et al.
Andrologia|November 9, 2020
Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinomaJulian Marcon, Matthias Trottmann, Severin Rodler, et al.
European Urology Focus|June 15, 2020
Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?Severin Rodler, Maria Apfelbeck, Gerald Bastian Schulz, et al.
Urologic Oncology|June 1, 2026
Survival association of GLP-1 receptor agonists and SGLT2 inhibitors in bladder cancer patientsJakob Kohler, Leonhard Buck, Patricia Schließer, et al.
Urologie (Heidelberg, Germany)|May 19, 2026
[Artificial intelligence in daily urological care: results of the AI barometer]Nicolas Carl, Frederik Wessels, Jonathan Jeutner, et al.
Urologia Internationalis|January 21, 2021
Does Pandemic Anxiety Affect Urology Health Care Workers?Maria Apfelbeck, Michael Staehler, Severin Rodler, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Journal of Geriatric Oncology|June 23, 2020
Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancersGerald Bastian Schulz, Severin Rodler, Bernadett Szabados, et al.
Sexual Medicine|May 22, 2020
Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional StudySeverin Rodler, Johannes von Büren, Alexander Buchner, et al.
Infection|February 24, 2022
Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient populationAlexander Tamalunas, Melanie Schott, Troya Ivanova, et al.
MMW Fortschritte Der Medizin|July 7, 2023
[Systemic treatment of renal cancer and management of immunotherapy related toxicity]Elena K Berg, Can Aydogdu, Melanie Götz, et al.
Urologic Oncology|September 18, 2021
Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatmentAnnabel Spek, Anno Graser, Jozefina Casuscelli, et al.
Andrologia|November 9, 2020
Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinomaJulian Marcon, Matthias Trottmann, Severin Rodler, et al.
European Urology Focus|June 15, 2020
Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?Severin Rodler, Maria Apfelbeck, Gerald Bastian Schulz, et al.
Urologic Oncology|June 1, 2026
Survival association of GLP-1 receptor agonists and SGLT2 inhibitors in bladder cancer patientsJakob Kohler, Leonhard Buck, Patricia Schließer, et al.
Urologie (Heidelberg, Germany)|May 19, 2026
[Artificial intelligence in daily urological care: results of the AI barometer]Nicolas Carl, Frederik Wessels, Jonathan Jeutner, et al.
Urologia Internationalis|January 21, 2021
Does Pandemic Anxiety Affect Urology Health Care Workers?Maria Apfelbeck, Michael Staehler, Severin Rodler, et al.
Pageof 13